+Hosted content

Practical tips for GPs switching an HFrEF patient to ENTRESTO from an ACEi or ARB

34% of NYHA class I-II Heart Failure patients with reduced Ejection Fraction die within 3 years!¹

The government passed regulations just before Christmas to enable Medicinal Cannabis to be prescribed by General Practitioners from 1st April 2020

Over a lifetime, an active person can walk the equivalent distance of five times around the equator!¹

It’s time to get excited about the inaugural New Zealand Primary Healthcare Awards | He Tohu Mauri Ora

Click here for V-Go^® free trial.

Are you treating your type 2 diabetes patients with insulin and do they still struggle to achieve their HbA1C target? Insulin injections might make patients feel uncomfortable in social circumstances while others are needle phobic, leading to poor compliance and increases in HbA1C

Your patient with type 2 diabetes is not reaching HbA1c target after lifestyle changes and treatment with metformin. So what next? Dr Rick Cutfield takes an expert look at the second-line treatment options available in New Zealand, including newly funded DPP-4 inhibitor vildagliptin.

Treating 23,500 elective day surgery patients in rural New Zealand is just part of the story. Education, training and workshops to support rural doctors and nurses is leaving a much bigger footprint

From 12 December 2018, the Champix^® (varenicline tartrate) quit smoking aid will be replaced by Varenicline Pfizer (varenicline tartrate). 

Frustrated by patients reporting they didn’t have access to information they needed, nurse Anna Mickell decided to find her own solution